UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055618
Receipt number R000063560
Scientific Title Exploratory intervention study on food intake in the growing age group
Date of disclosure of the study information 2024/09/25
Last modified on 2025/09/25 10:09:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory intervention study on food intake in the growing age group

Acronym

Exploratory intervention study on food intake in the growing age group

Scientific Title

Exploratory intervention study on food intake in the growing age group

Scientific Title:Acronym

Exploratory intervention study on food intake in the growing age group

Region

Japan


Condition

Condition

None

Classification by specialty

Not applicable Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of 8 weeks of intake of fermented milk protein on exercise performance and cognitive function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Exercise performance
(1) Rebound jump
(2) Counter movement jump
(3) Standing long jump
(4) 20 m sprint
(5) Yo-Yo test

Key secondary outcomes

(1) Gut microbiota
(2) Cognitive test
(3) Height, weight and sitting height
(4) Body composition
(5) Sleep status evaluation
(6) Nutrition survey


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Oral intake of the study food 1(8 weeks)

Interventions/Control_2

Oral intake of the study food 2(8 weeks)

Interventions/Control_3

Oral intake of the placebo study food(8 weeks)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

12 years-old >=

Gender

Male

Key inclusion criteria

Children who play soccer at least once a week.

Key exclusion criteria

1) Children who have difficulty undergoing the same physical fitness tests as able-bodied individuals due to physical, intellectual or mental disabilities.
2) Children who are not medically permitted to fully participate in sports or exercise due to illnesses such as heart disease.
3) Children whose health may be adversely affected by ingesting the test foods due to allergies, lactose intolerance, etc.

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Atsushi
Middle name
Last name Kanda

Organization

Meiji Co., Ltd.

Division name

Nutrition Development Research Unit. R&D Division

Zip code

192-0919

Address

1-29-1 Nanakuni, Hachiouji, Tokyo

TEL

080-8131-5912

Email

atsushi.kanda.ba@meiji.com


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Urushizawa

Organization

Euphoria Co., Ltd

Division name

Data Management Group

Zip code

102-0085

Address

5-5 Rokubancho, Chiyoda, Tokyo

TEL

080-3321-0048

Homepage URL


Email

sdm@eu-phoria.jp


Sponsor or person

Institute

Euphoria Co., Ltd

Institute

Department

Personal name



Funding Source

Organization

Meiji Co., Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Euphoria Co., Ltd

Address

5-5 Rokubancho, Chiyoda, Tokyo

Tel

080-3321-0048

Email

Team-rd@eu-phoria.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

44

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 09 Month 09 Day

Date of IRB

2024 Year 09 Month 09 Day

Anticipated trial start date

2024 Year 09 Month 25 Day

Last follow-up date

2024 Year 12 Month 26 Day

Date of closure to data entry


Date trial data considered complete

2025 Year 02 Month 21 Day

Date analysis concluded

2025 Year 12 Month 30 Day


Other

Other related information



Management information

Registered date

2024 Year 09 Month 25 Day

Last modified on

2025 Year 09 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063560